Although a possible common pathogenic mechanism involving the von Willebrand factor between ABO blood group system and cancer/cardiovascular disease has been discussed [6], the relationship between histoblood group antigens and inflammation related diseases remains unknown and the regulatory mechanisms underlying ABO expression was still unclear. This evidence concerns the gene ABO and cancer.